ESCRS Practice Management and Development Masterclass


Colin Kerr
Published: Friday, September 2, 2016
The secrets to growing your refractive practice using proven, affordable and measurable digital tactics will be revealed at the ESCRS Practice Management and Development Masterclass, to be held during the XXXIV Congress of the ESCRS on Sunday September 11.
Three global refractive marketing experts will conduct the workshop, which includes small breakout sessions for practices of all sizes to help them learn the latest marketing skills and how to implement proven ‘best practice’ strategies.
“The faculty I have invited features two of the very best ophthalmic digital and social media experts in their field, and the content they will be sharing is truly invaluable to today’s practices. Leonard Melcher II and Michael King have rocketed to the top of their respective fields in digital and refractive marketing because of their tremendous front-line success in some of the world’s most competitive markets,” said course director Mike Malley.
.....
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.